Facteus Doubles its Data Size, Unveiling Ultra, the Alternative Data Industry’s Largest and 1-Day Lag Consumer Transaction Data Product
Now incorporates more debit and credit card data than any other product in the market…
Year: 2023
Curia Expands Cell Line Development Offering with CHOZN Platform
Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies ALBANY, N.Y.,…
Curia Expands Cell Line Development Offering with CHOZN Platform
Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies ALBANY, N.Y.,…
AssistRx Launches Advanced Gateway to Address Increasing Demands of Patient Support Programs
Single API Integration Delivers Tech-first Access Solutions, Comprehensive Program Insights and Reduced Implementation Time ORLANDO,…
AssistRx Launches Advanced Gateway to Address Increasing Demands of Patient Support Programs
Single API Integration Delivers Tech-first Access Solutions, Comprehensive Program Insights and Reduced Implementation Time ORLANDO,…
ADvantage Therapeutics Secures Approvals for Clinical Trial of AD04™ in Alzheimer’s Disease Treatment in Poland, Bulgaria, and Slovakia
MIAMI, June 20, 2023 (GLOBE NEWSWIRE) — ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), a…
ADvantage Therapeutics Secures Approvals for Clinical Trial of AD04™ in Alzheimer’s Disease Treatment in Poland, Bulgaria, and Slovakia
MIAMI, June 20, 2023 (GLOBE NEWSWIRE) — ADvantage Therapeutics, Inc. (“ADvantage” or “the Company”), a…
ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company’s Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens
YONKERS, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
ContraFect Data Presentations at ASM Microbe 2023 Demonstrate the Power of the Company’s Proprietary Platform to Discover New Agents Targeting Antibiotic-Resistant Gram-negative Pathogens
YONKERS, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology…
Galecto Set to Join Russell Microcap® Index
BOSTON, June 20, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
Galecto Set to Join Russell Microcap® Index
BOSTON, June 20, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company…
Gracell Biotechnologies to Participate in Truist Securities Cell Therapy Symposium
SAN DIEGO and SUZHOU and SHANGHAI, China, June 20, 2023 (GLOBE NEWSWIRE) — Gracell Biotechnologies…
Gracell Biotechnologies to Participate in Truist Securities Cell Therapy Symposium
SAN DIEGO and SUZHOU and SHANGHAI, China, June 20, 2023 (GLOBE NEWSWIRE) — Gracell Biotechnologies…
PaxMedica CEO Interviewed by The BRAIN Foundation
Webcast Link Available at PaxMedica.com TARRYTOWN, NY, June 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire…
PaxMedica CEO Interviewed by The BRAIN Foundation
Webcast Link Available at PaxMedica.com TARRYTOWN, NY, June 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire…
BioSyent Announces Long-term Extension of Cathejell® Agreement
MISSISSAUGA, Ontario, June 20, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
BioSyent Announces Long-term Extension of Cathejell® Agreement
MISSISSAUGA, Ontario, June 20, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million
Grant Funding received to date from the Australian Federal Government totals USD $3.25 million NEW…
Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million
Grant Funding received to date from the Australian Federal Government totals USD $3.25 million NEW…
ABVC BioPharma Subsidiary BioKey Projects $1.0 Million Proceeds From Dietary Supplement Production
FREMONT, CA, June 20, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — ABVC BioPharma, Inc. (NASDAQ:…